|
Market Closed -
Nasdaq
04:00:00 2026-08-27 pm EDT
|
5-day change | 1st Jan Change | ||
| 10.02 USD | 0.00% |
|
-0.69% | +62.93% |
| Aug. 14 | ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026 | |
| Aug. 13 | ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 91M | - | - | - | - | - |
| 1,048B | |||||
| 640B | - | - | - | ||
| 456B | |||||
| 362B | |||||
| 295B |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
